Oncodesign Precision Medicine (XPAR:ALOPM) Cash per Share : €0.22 (As of Jun. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Cash per Share?

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Oncodesign Precision Medicine's Cash per Share for the quarter that ended in Jun. 2022 was €0.22.

Oncodesign Precision Medicine Cash per Share Historical Data

The historical data trend for Oncodesign Precision Medicine's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Cash per Share Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Cash per Share

1.23

0.72

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22
Cash per Share	1.23	0.72	0.22

Oncodesign Precision Medicine Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Oncodesign Precision Medicine's Cash per Share for the fiscal year that ended in Dec. 2021 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	4.921	/	6.85
	=	0.72

Oncodesign Precision Medicine's Cash per Share for the quarter that ended in Jun. 2022 is calculated as:

Cash per Share	=	Cash, Cash Equivalents, Marketable Securities	/	Shares Outstanding (EOP)
	=	1.501	/	6.85
	=	0.22

Oncodesign Precision Medicine (XPAR:ALOPM) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.

Oncodesign Precision Medicine Cash per Share Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine (XPAR:ALOPM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Cash per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine (XPAR:ALOPM) Headlines

No Headlines